nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—neck—pharynx cancer	0.0789	0.129	CbGeAlD
Pseudoephedrine—TNF—EBV LMP1 signaling—PDLIM7—pharynx cancer	0.0616	0.159	CbGpPWpGaD
Pseudoephedrine—IL2—epithelium—pharynx cancer	0.0537	0.0878	CbGeAlD
Pseudoephedrine—NFATC1—lymphoid tissue—pharynx cancer	0.0452	0.074	CbGeAlD
Pseudoephedrine—IL2—lymphoid tissue—pharynx cancer	0.0414	0.0676	CbGeAlD
Pseudoephedrine—NFATC1—head—pharynx cancer	0.0364	0.0596	CbGeAlD
Pseudoephedrine—IL2—head—pharynx cancer	0.0333	0.0545	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—pharynx cancer	0.0255	0.0417	CbGeAlD
Pseudoephedrine—TNF—lymph node—pharynx cancer	0.0243	0.0398	CbGeAlD
Pseudoephedrine—IL2—lymph node—pharynx cancer	0.0233	0.0382	CbGeAlD
Pseudoephedrine—TNF—Matrix Metalloproteinases—MMP8—pharynx cancer	0.0223	0.0573	CbGpPWpGaD
Pseudoephedrine—NFATC1—BCR signaling pathway—CD79A—pharynx cancer	0.0209	0.0539	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0187	0.048	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0164	0.0421	CbGpPWpGaD
Pseudoephedrine—SLC6A3—brainstem—pharynx cancer	0.0159	0.0261	CbGeAlD
Pseudoephedrine—MAOA—neck—pharynx cancer	0.0155	0.0254	CbGeAlD
Pseudoephedrine—SLC6A4—brainstem—pharynx cancer	0.0146	0.0239	CbGeAlD
Pseudoephedrine—NFATC1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—pharynx cancer	0.014	0.036	CbGpPWpGaD
Pseudoephedrine—SLC6A2—brainstem—pharynx cancer	0.0129	0.021	CbGeAlD
Pseudoephedrine—MAOA—parotid gland—pharynx cancer	0.0126	0.0206	CbGeAlD
Pseudoephedrine—MAOA—saliva-secreting gland—pharynx cancer	0.0121	0.0198	CbGeAlD
Pseudoephedrine—MAOA—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0121	0.031	CbGpPWpGaD
Pseudoephedrine—ADRA1A—brainstem—pharynx cancer	0.012	0.0195	CbGeAlD
Pseudoephedrine—MAOA—brainstem—pharynx cancer	0.0118	0.0194	CbGeAlD
Pseudoephedrine—ADRA1A—epithelium—pharynx cancer	0.0106	0.0174	CbGeAlD
Pseudoephedrine—MAOA—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0106	0.0272	CbGpPWpGaD
Pseudoephedrine—SLC6A3—spinal cord—pharynx cancer	0.00991	0.0162	CbGeAlD
Pseudoephedrine—MAOA—trachea—pharynx cancer	0.00933	0.0153	CbGeAlD
Pseudoephedrine—SLC6A4—spinal cord—pharynx cancer	0.00908	0.0148	CbGeAlD
Pseudoephedrine—SLC6A4—NRF2 pathway—ADH7—pharynx cancer	0.00891	0.0229	CbGpPWpGaD
Pseudoephedrine—SLC6A3—head—pharynx cancer	0.00881	0.0144	CbGeAlD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—CCND1—pharynx cancer	0.0084	0.0216	CbGpPWpGaD
Pseudoephedrine—ADRB1—head—pharynx cancer	0.00835	0.0137	CbGeAlD
Pseudoephedrine—ADRA1A—lymphoid tissue—pharynx cancer	0.0082	0.0134	CbGeAlD
Pseudoephedrine—SLC6A4—head—pharynx cancer	0.00807	0.0132	CbGeAlD
Pseudoephedrine—IL2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.0078	0.0201	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—ADH7—pharynx cancer	0.00766	0.0197	CbGpPWpGaD
Pseudoephedrine—MAOA—spinal cord—pharynx cancer	0.00736	0.012	CbGeAlD
Pseudoephedrine—IL2—Regulation of Telomerase—CCND1—pharynx cancer	0.00727	0.0187	CbGpPWpGaD
Pseudoephedrine—ADRA2A—trachea—pharynx cancer	0.00716	0.0117	CbGeAlD
Pseudoephedrine—SLC6A2—head—pharynx cancer	0.0071	0.0116	CbGeAlD
Pseudoephedrine—IL2—AP-1 transcription factor network—CCND1—pharynx cancer	0.0071	0.0183	CbGpPWpGaD
Pseudoephedrine—MAOA—Biological oxidations—CNDP2—pharynx cancer	0.00709	0.0182	CbGpPWpGaD
Pseudoephedrine—CYP2D6—brainstem—pharynx cancer	0.00704	0.0115	CbGeAlD
Pseudoephedrine—SLC6A3—NRF2 pathway—ADH7—pharynx cancer	0.00679	0.0175	CbGpPWpGaD
Pseudoephedrine—ADRA1A—head—pharynx cancer	0.0066	0.0108	CbGeAlD
Pseudoephedrine—MAOA—head—pharynx cancer	0.00655	0.0107	CbGeAlD
Pseudoephedrine—IL2—SHP2 signaling—EGFR—pharynx cancer	0.00648	0.0167	CbGpPWpGaD
Pseudoephedrine—MAOA—Biological oxidations—ADH7—pharynx cancer	0.00641	0.0165	CbGpPWpGaD
Pseudoephedrine—IL2—Regulation of Telomerase—EGFR—pharynx cancer	0.0057	0.0147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—spinal cord—pharynx cancer	0.00565	0.00924	CbGeAlD
Pseudoephedrine—MAOA—Biological oxidations—ADH1B—pharynx cancer	0.00562	0.0145	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—TP53—pharynx cancer	0.00553	0.0142	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00525	0.0135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—head—pharynx cancer	0.00502	0.00821	CbGeAlD
Pseudoephedrine—SLC6A2—lymph node—pharynx cancer	0.00497	0.00814	CbGeAlD
Pseudoephedrine—IL2—Folate Metabolism—TP53—pharynx cancer	0.0049	0.0126	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00487	0.0125	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—TP53—pharynx cancer	0.00468	0.012	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—CCND1—pharynx cancer	0.00468	0.012	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00461	0.0119	CbGpPWpGaD
Pseudoephedrine—MAOA—lymph node—pharynx cancer	0.00458	0.0075	CbGeAlD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00412	0.0106	CbGpPWpGaD
Pseudoephedrine—ADRB2—Arf6 trafficking events—CDH1—pharynx cancer	0.00402	0.0104	CbGpPWpGaD
Pseudoephedrine—CYP2D6—head—pharynx cancer	0.00389	0.00636	CbGeAlD
Pseudoephedrine—NFATC1—Disease—B4GALT5—pharynx cancer	0.00367	0.00945	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—EGFR—pharynx cancer	0.00367	0.00944	CbGpPWpGaD
Pseudoephedrine—ADRA2A—lymph node—pharynx cancer	0.00352	0.00575	CbGeAlD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00327	0.00842	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00314	0.00807	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00308	0.00794	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TP53—pharynx cancer	0.00308	0.00793	CbGpPWpGaD
Pseudoephedrine—ADRB2—Arf6 signaling events—EGFR—pharynx cancer	0.00298	0.00766	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.0029	0.00747	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.0029	0.00747	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—pharynx cancer	0.00284	0.0073	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00279	0.00718	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TP53—pharynx cancer	0.00275	0.00707	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00245	0.0063	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD79A—pharynx cancer	0.00218	0.00561	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CDH1—pharynx cancer	0.00188	0.00483	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD79A—pharynx cancer	0.00184	0.00474	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—pharynx cancer	0.00182	0.0047	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—CCND1—pharynx cancer	0.00174	0.00448	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—pharynx cancer	0.00158	0.00407	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—pharynx cancer	0.0015	0.00387	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—EGFR—pharynx cancer	0.00137	0.00351	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EGFR—pharynx cancer	0.00122	0.00314	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CDH1—pharynx cancer	0.00121	0.00312	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CNDP2—pharynx cancer	0.00121	0.00312	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—pharynx cancer	0.0012	0.00309	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00118	0.00305	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—pharynx cancer	0.00115	0.00295	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ADH7—pharynx cancer	0.0011	0.00282	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00103	0.00265	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CDH1—pharynx cancer	0.00103	0.00264	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—pharynx cancer	0.000961	0.00247	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ADH1B—pharynx cancer	0.000961	0.00247	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000929	0.00239	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—pharynx cancer	0.000922	0.00237	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—B4GALT5—pharynx cancer	0.000918	0.00236	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—pharynx cancer	0.000867	0.00223	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—pharynx cancer	0.000864	0.00222	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CNDP2—pharynx cancer	0.00081	0.00208	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00078	0.00201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ADH7—pharynx cancer	0.000732	0.00188	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—pharynx cancer	0.00071	0.00183	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—pharynx cancer	0.000657	0.00169	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—pharynx cancer	0.000655	0.00169	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ADH1B—pharynx cancer	0.000642	0.00165	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—B4GALT5—pharynx cancer	0.000614	0.00158	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—pharynx cancer	0.0006	0.00155	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCND1—pharynx cancer	0.000585	0.00151	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000577	0.00148	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000528	0.00136	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCND1—pharynx cancer	0.000495	0.00127	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000477	0.00123	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—pharynx cancer	0.000459	0.00118	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—pharynx cancer	0.000434	0.00112	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000418	0.00108	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.0004	0.00103	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—pharynx cancer	0.000388	0.000999	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—pharynx cancer	0.000385	0.000992	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—pharynx cancer	0.000326	0.000839	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—pharynx cancer	0.000227	0.000584	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—pharynx cancer	0.000206	0.000531	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—pharynx cancer	0.000202	0.000519	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—pharynx cancer	0.000167	0.000429	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—pharynx cancer	0.000155	0.0004	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—pharynx cancer	0.000155	0.000399	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—pharynx cancer	0.000152	0.000391	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—pharynx cancer	0.000126	0.000323	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—pharynx cancer	0.000122	0.000313	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—pharynx cancer	0.000119	0.000307	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—pharynx cancer	0.000117	0.0003	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—pharynx cancer	0.000102	0.000263	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—pharynx cancer	0.0001	0.000257	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—pharynx cancer	9.86e-05	0.000254	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—pharynx cancer	9.16e-05	0.000236	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—pharynx cancer	8.28e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—pharynx cancer	7.69e-05	0.000198	CbGpPWpGaD
